my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
SIRION Biotech is Europe's leading commercial supplier of viral vectors used for genetic cell modelling, gene target validation and gene therapy- and vaccination studies. Since its foundation in 2007, SIRION’s mission has been to change the paradigm for viral vector supplies. It has the ability to more
Richter-Helm is a Hamburg, Germany-based contract development and manufacturing company specialized in products derived from bacteria and yeasts, with a proven 25-year track record. Count on us to flexibly provide a comprehensive range of services and customized solutions. Clients worldwide have al more
CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 18 years’ expertise in handling and optimizing this versatile molecule for medical purposes. The principle of CureVac's proprietary technology is the use of mRNA as a data carrier to instruct the human body t more
The producer of high-tech laboratory systems, KNAUER Wissenschaftliche Geräte GmbH was awarded the Innovation Prize for the Berlin Brandenburg region for their new system for the production of lipid nanoparticles (LNPs). The systems, developed and manufactured in Berlin, play a key role in the prod more
ContiVir, a planned spin-off from the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has been awarded the 2021 "Innovation Prize of the German BioRegions" with regard to their research on and development of a purification tool to tackle vaccine bottlenecks. This national a more
Prime Vector Technologies (PRIME), a Biotech Startup focusing on the development of viral vector based vaccines, and Boehringer Ingelheim, a leading global research-based pharmaceutical company, announce that they have entered a strategic collaboration, option and licence agreement. The collaboratio more
Pathogens are continuously emerging and evolving. Addressing the threat of new and potentially life-threatening pathogens requires deep understanding more
By now, we’re all familiar with the image of coronavirus. The spikey blob peppers news websites, looms behind reporters during bulletins and frequently punctuates your Twitter doom-scrolling. More recently, the news accompanying this image has taken a positive turn, with promising results from the C more
The recent measles outbreak in the US has once again provoked discussion over vaccinations, and why some parents choose not to vaccinate their children despite the benefits of doing so. Whilst not the only factor, part of the blame lies with misinformation about the chemical composition of vaccines more
Viruses, Vol. 10, Pages 347: Protection against Virulent Infectious Bronchitis Virus Challenge Conferred by a Recombinant Baculovirus Co-Expressing S1 and N Proteins Viruses doi: 10.3390/v10070347 Authors: Yuan Yuan Zhi-Peng Zhang Yi-Ning He Wen-Sheng Fan Zhi-Hua Dong Li-Hua Zhang more
Abstract Trypanosoma brucei is a pathogenic protozoa that causes chronic Human African Trypanosomiasis and African Animal Trypanosomiasis. The pathogenic parasite is transmitted to humans by the tsetse fly, Glossina m. morsitans. Trypanosomiasis control strategies have targeted either the tsetse ve more
Viruses, Vol. 10, Pages 325: A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase Viruses doi: 10.3390/v10060325 Authors: Ping Li Qinghua Cui Lin Wang Xiujuan Zhao Yingying Zhang Balaji Manicassamy Yong Yang more
Timeline of vaccines This is a timeline of the development of prophylactic human vaccine s. Early vaccines may be listed by the first year of development or testing, but later entries usually show the year the vaccine finished trials and became ... more
Watchlist
This is where you can add this topic to your personal favourites
© 1997-2021 LUMITOS AG, All rights reserved
